Subtype
Skin Fibroblastic Neoplasm
CI-CAN-00001514Explore in graph →
Non-malignant4 active trials9 evidence items
- NCIt
- C4634
Loading cancer entity…
Subtype
CI-CAN-00001514Explore in graph →
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01962103 | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 107 | CelgeneINDUSTRY | 7 | Dec 27, 2019 | clinicaltrials |
| NCT01154452 | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma | completed | Phase 1 / Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Aug 15, 2018 | clinicaltrials |
| NCT00720174 | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 17, 2016 | clinicaltrials |
| NCT00122473 |
Data updated 23 days agoSource updated Dec 27, 2019source: clinicaltrials
| Imatinib in Dermatofibrosarcoma Protuberans (DFSP) |
| completed |
| Phase 1 / Phase 2 |
| 30 |
| Dermatologic Cooperative Oncology GroupOTHER |
| 1 |
| Jul 29, 2011 |
| clinicaltrials |